Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis

被引:156
|
作者
Mainz, J. G. [1 ]
Naehrlich, L. [2 ]
Schien, M. [1 ]
Kaeding, M. [3 ]
Schiller, I. [1 ]
Mayr, S.
Schneider, G.
Wiedemann, B. [4 ]
Wiehlmann, L. [5 ]
Cramer, N. [5 ]
Pfister, W. [6 ]
Kahl, B. C. [7 ]
Beck, J. F. [1 ]
Tuemmler, B. [5 ]
机构
[1] Univ Hosp Jena, Dept Pediat, CF Ctr, Jena, Germany
[2] Univ Erlangen Nurnberg, Dept Pediat, CF Ctr, D-8520 Erlangen, Germany
[3] Chemnitz Hosp, CF Ctr, Chemnitz, Germany
[4] Univ Dresden, Dept Med Informat & Biometr, Dresden, Germany
[5] Hannover Med Sch, Klin Forschergrp, Hannover, Germany
[6] Univ Hosp Jena, Inst Med Microbiol, Jena, Germany
[7] Univ Hosp Munster, Inst Med Microbiol, Munster, Germany
关键词
LUNG-TRANSPLANT RECIPIENTS; CLINICAL CHARACTERISTICS; COLONIZATION; BACTERIOLOGY; INFECTIONS; SINUSITIS; SURVIVAL; SINUSES;
D O I
10.1136/thx.2008.104711
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Rationale: Lower airway (LAW) infection with Pseudomonas aeruginosa and Staphylococcus aureus is the leading cause of morbidity in cystic fibrosis (CF). The upper airways (UAW) were shown to be a gateway for acquisition of opportunistic bacteria and to act as a reservoir for them. Therefore, tools for UAW assessment within CF routine care require evaluation. Objectives: The aims of the study were non-invasive assessment of UAW and LAW microbial colonisation, and genotyping of P aeruginosa and S aureus strains from both segments. Methods: 182 patients with CF were evaluated (age 0.4-68 years, median 17 years). LAW specimens were preferably sampled as expectorated sputum and UAW specimens by nasal lavage. P aeruginosa and S aureus isolates were typed by informative single nucleotide polymorphisms (SNPs) or by spa typing, respectively. Results: Of the typable S aureus and P aeruginosa isolates from concomitant UAW- and LAW-positive specimens, 31 of 36 patients were carrying identical S aureus spa types and 23 of 24 patients identical P aeruginosa SNP genotypes in both compartments. Detection of S aureus or P aeruginosa in LAW specimens was associated with a 15- or 88-fold higher likelihood also to identify S aureus or P aeruginosa in a UAW specimen from the same patient. Conclusions: The presence of identical genotypes in UAW and LAW suggests that the UAW play a role as a reservoir of S aureus and P aeruginosa in CF. Nasal lavage appears to be suitable for non-invasive UAW sampling, but further longitudinal analyses and comparison with invasive methods are required. While UAW bacterial colonisation is typically not assessed in regular CF care, the data challenge the need to discuss diagnostic and therapeutic standards for this airway compartment. Trial registration number: NCT00266474.
引用
收藏
页码:535 / 540
页数:6
相关论文
共 50 条
  • [21] Genotype based evaluation of Pseudomonas aeruginosa eradication treatment success in cystic fibrosis patients
    Schelstraete, Petra
    Deschaght, Pieter
    Van Simaey, Leen
    Van Daele, Sabine
    Haerynck, Filomeen
    Vaneechoutte, Mario
    De Baets, Frans
    JOURNAL OF CYSTIC FIBROSIS, 2010, 9 (02) : 99 - 103
  • [22] In vitro pharmacodynamics of ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients
    Manduru, M
    Mihm, LB
    White, RL
    Friedrich, LV
    Flume, PA
    Bosso, JA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (09) : 2053 - 2056
  • [23] Initial Pseudomonas aeruginosa infection in patients with cystic fibrosis: characteristics of eradicated and persistent isolates
    Tramper-Stranders, G. A.
    van der Ent, C. K.
    Molin, S.
    Yang, L.
    Hansen, S. K.
    Rau, M. H.
    Ciofu, O.
    Johansen, H. K.
    Wolfs, T. F. W.
    CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 (06) : 567 - 574
  • [24] Comparison of three typing methods for Pseudomonas aeruginosa isolates from patients with cystic fibrosis
    Waters, V.
    Zlosnik, J. E. A.
    Yau, Y. C. W.
    Speert, D. P.
    Aaron, S. D.
    Guttman, D. S.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2012, 31 (12) : 3341 - 3350
  • [25] Cystic Fibrosis Isolates of Pseudomonas aeruginosa Retain Iron-Regulated Antimicrobial Activity against Staphylococcus aureus through the Action of Multiple Alkylquinolones
    Nguyen, Angela T.
    Jones, Jace W.
    Camara, Miguel
    Williams, Paul
    Kane, Maureen A.
    Oglesby-Sherrouse, Amanda G.
    FRONTIERS IN MICROBIOLOGY, 2016, 7
  • [26] Acquisition and eradication of P. aeruginosa in young children with cystic fibrosis
    Douglas, T. A.
    Brennan, S.
    Gard, S.
    Berry, L.
    Gangell, C.
    Stick, S. M.
    Clements, B. S.
    Sly, P. D.
    EUROPEAN RESPIRATORY JOURNAL, 2009, 33 (02) : 305 - 311
  • [27] Antimicrobial Activity of Tobramycin Against Respiratory Cystic Fibrosis Pseudomonas aeruginosa Isolates from Bulgaria
    Strateva, T.
    Petrova, G.
    Mitov, I.
    JOURNAL OF CHEMOTHERAPY, 2010, 22 (06) : 378 - 383
  • [28] Importance of superoxide dismutases A and M for protection of Staphylococcus aureus in the oxidative stressful environment of cystic fibrosis airways
    Treffon, Janina
    Chaves-Moreno, Diego
    Niemann, Silke
    Pieper, Dietmar Helmut
    Vogl, Thomas
    Roth, Johannes
    Kahl, Barbara C.
    CELLULAR MICROBIOLOGY, 2020, 22 (05)
  • [29] Network Analysis to Identify Multi-Omic Correlations in the Lower Airways of Children With Cystic Fibrosis
    O'Connor, John B.
    Mottlowitz, Madison
    Kruk, Monica E.
    Mickelson, Alan
    Wagner, Brandie D.
    Harris, Jonathan Kirk
    Wendt, Christine H.
    Laguna, Theresa A.
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [30] Rapid and quantitative automated measurement of bacteriophage activity against cystic fibrosis isolates of Pseudomonas aeruginosa
    Cooper, C. J.
    Denyer, S. P.
    Maillard, J. -Y.
    JOURNAL OF APPLIED MICROBIOLOGY, 2011, 110 (03) : 631 - 640